Cases

The rise of 'bio-based' textiles—derived from plants, algae, or mycelium—has been touted as a sustainable alternative to petroleum-based synthetics. However, many such materials are not actually biodegradable under real-world conditions, and some require industrial composting facilities that are rarely available. In early 2026, the European Commission proposed stricter labeling rules for bio-based products, while the FTC in the U.S. is investigating greenwashing claims in apparel marketing. Brands like Stella McCartney and Pangaia promote bio-based innovations, yet independent lifecycle assessments often reveal limited end-of-life benefits. This raises a critical dilemma: should regulatory frameworks mandate proof of actual biodegradability before allowing 'bio-based' claims? The stakes involve consumer trust, environmental impact, and the integrity of circular economy initiatives.

Beauty brands like L'Oréal and Estée Lauder are increasingly using AI-generated 'virtual models' to showcase products, citing inclusivity, cost efficiency, and creative control. These digital avatars can represent diverse skin tones, ages, and features without the limitations of physical casting. However, dermatologists and consumer advocates warn that AI models often present unrealistic skin perfection, potentially exacerbating body image issues and undermining transparency about product efficacy. In 2026, the UK's Advertising Standards Authority began reviewing guidelines on digitally altered imagery, while the American Academy of Dermatology called for disclosure when AI models are used. This trial examines whether the benefits of AI models outweigh their psychological and ethical risks in beauty marketing.

Encaustic painting—using heated beeswax mixed with pigments—is experiencing a resurgence among contemporary artists drawn to its luminous texture and durability. Scientific studies, including 2024 research from the Getty Conservation Institute, confirm encaustic's exceptional lightfastness and resistance to environmental degradation compared to acrylics and even some oils. Yet the medium demands specialized equipment, ventilation, and safety protocols, raising barriers to entry. Critics question whether its archival benefits justify the cost and complexity, especially when modern synthetic paints offer improved longevity. Supporters argue that encaustic's material integrity and historical continuity (dating to ancient Egypt and Greece) offer conceptual depth beyond mere preservation. As climate change threatens art storage conditions globally, should artists prioritize inherently stable materials—even if they're less accessible?

Cities worldwide are rethinking public art after controversies over monuments and culturally insensitive installations. In 2025, municipalities like Minneapolis and Barcelona adopted policies requiring artists to engage local residents in the design process for publicly funded works. Proponents argue co-creation fosters ownership, reflects authentic community narratives, and prevents alienating or appropriative art. Critics—including many established artists—warn that committee-driven art dilutes vision, stifles challenging work, and conflates popularity with artistic merit. The tension lies between art as democratic expression versus art as individual genius. With public funding increasingly tied to equity goals, this question challenges foundational notions of authorship, aesthetic autonomy, and civic responsibility in the arts.

The NFT art market continues to evolve amid growing use of generative AI in creation processes. While some artists transparently integrate AI as a collaborative tool, others mint works without disclosing AI's role—raising authenticity and value concerns. In early 2025, major platforms like Foundation and Zora began debating mandatory disclosure policies after collectors discovered AI-generated elements in works marketed as 'hand-crafted.' The issue intersects with intellectual property, artistic labor, and collector trust. Traditional digital artists argue that undisclosed AI use constitutes deception, especially when pricing reflects human effort. AI artists counter that all tools evolve, and demanding disclosure stigmatizes innovation. With the NFT market seeking legitimacy post-hype, transparency may be key to sustainable growth—but at what cost to creative freedom?

Museums worldwide face increasing pressure to maintain both physical collections and digital archives. With climate change, aging infrastructure, and evolving audience expectations, institutions must allocate limited resources wisely. Recently, the Baltimore Museum of Art and others have explored deaccessioning works—selling pieces from their permanent collections—to fund operational needs, including digitization and digital conservation. The Association of Art Museum Directors (AAMD) historically restricted deaccessioning proceeds to acquiring new art, but temporarily relaxed these rules during the pandemic. Now, as digital access becomes central to public engagement and scholarship, some argue that using deaccession funds for digital preservation is a responsible adaptation. Opponents warn this sets a dangerous precedent, commodifying cultural heritage and risking the loss of public trust. This dilemma forces a reckoning: is digitizing art a form of preservation equal to conserving physical objects, and does it justify selling originals?

Digital artists increasingly rely on AI tools like Adobe Color, Coolors, and MidJourney to generate harmonious color palettes instantly. These tools use algorithms trained on vast datasets of successful artworks and design principles, often producing aesthetically pleasing results with minimal effort. While efficient, this trend raises concerns among art educators and traditional color theorists: are emerging artists bypassing foundational learning in hue relationships, emotional resonance, and cultural context of color? Recent studies from art schools show declining performance in manual color mixing and theory exams among students who heavily use AI palette generators. Yet proponents argue AI democratizes access to sophisticated color harmony, allowing artists to focus on concept over technical execution. The core question is whether AI tools enhance or erode the deep understanding of color necessary for intentional artistic expression.

Emerging clinical observations and patient reports suggest GLP-1 receptor agonists (e.g., semaglutide) may reduce cravings not only for food but also for alcohol, nicotine, and other substances. Small studies and case series (2023–2024) indicate potential modulation of dopamine reward pathways, offering a novel pharmacological avenue in addiction recovery. However, robust RCTs are lacking, and long-term effects on relapse prevention are unknown. Some addiction specialists caution against overreliance on pharmaceutical solutions without behavioral support, while others see promise for treatment-resistant cases. This trial evaluates whether GLP-1 agonists should be integrated into evidence-based addiction recovery protocols.

In 2021, the U.S. Preventive Services Task Force (USPSTF) lowered the recommended starting age for colorectal cancer (CRC) screening from 50 to 45 due to rising incidence in younger adults. However, the absolute risk for 45–49-year-olds remains low (~0.14% lifetime risk before 50), and colonoscopy carries procedural risks (perforation, bleeding) and resource burdens. Alternative non-invasive tests like stool DNA (Cologuard) or FIT are available but less sensitive for precancerous polyps. Debate centers on whether the modest reduction in CRC mortality justifies population-wide invasive screening in this age group, especially given disparities in access and potential for overdiagnosis. This trial weighs the public health benefit against individual risk and healthcare system strain.

Home sleep apnea tests (HSATs) have gained popularity due to convenience, lower cost, and expanded telemedicine access. The American Academy of Sleep Medicine now endorses HSATs for uncomplicated obstructive sleep apnea (OSA) in adults without significant comorbidities. However, HSATs miss central sleep apnea, underestimate severity in mild cases, and have higher failure rates due to user error. In-lab polysomnography remains the gold standard but is costly and less accessible. With rising OSA prevalence and telehealth expansion, this trial examines whether HSATs provide sufficient diagnostic accuracy to justify widespread first-line use, especially as AI-enhanced wearables enter the market.